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Background
Specific acute treatments of migraine are 5HT1B/D recep-
tor agonists, i.e. triptans and ergotamine. No migraine
prophylactic drugs are specific to migraine. Prophylactic
drugs are selected by time consuming “trial and error”.
Personalized treatment is therefore much needed.
Aim
The objective of this study was to test the effect of 12
common SNPs significantly associated with migraine on
migraine drug responses.
Methods
Semi-structured migraine interviews, blood samples and
genotyping were performed on 1806 unrelated migraine
cases recruited from the Danish Headache Center. Asso-
ciation analyses were carried out using logistic regression
and ORs were calculated assuming an additive model for
risk. The effect on drug responses was tested for a com-
bined genetic score and for each of the 12 SNPs.
Results
A higher combined genetic score, and a single SNP,
rs2651899 in PRDM16, were significantly associated
with efficacy of triptans with an OR of success of 2.6
and 1.3, respectively. A number of SNPs showed nom-
inal preferential association with the efficacy of triptans
and others with prophylactic drugs.
Conclusion
We show for the first time an association between
genetic constitution and migraine drug response. This is
a first step towards future individualized medicine.
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